592 Enhancing the therapeutic potential of oncolytic adenoviruses with vSENS™ technology

• Goo-Young Kim,
• Ji Yeon Son,
• So Jin Lee,
• Sang Woo Jo,
• Changhoon In,
• Sang Hoon Kim,
• Joon Young Park,
• So-Young Kim,
• Gyu-Young Moon,
• Ji-Hye Choi,
• Suk-Hwan Kim,
• Minhyuk Yun,
• Hye Yeong Nam,
• Helen Cho

Affiliations

Goo-Young Kim

Samyang Biopharmaceuticals Corporation, Gyeonggi-do, Korea, Republic of

Ji Yeon Son

Samyang Biopharmaceuticals Corporation, Gyeonggi-do, Korea, Republic of

So Jin Lee

Samyang Biopharmaceuticals Corporation, Gyeonggi-do, Korea, Republic of

Sang Woo Jo

Samyang Biopharmaceuticals Corporation, Gyeonggi-do, Korea, Republic of

Changhoon In

Samyang Biopharmaceuticals Corporation, Gyeonggi-do, Korea, Republic of

Sang Hoon Kim

Samyang Biopharmaceuticals Corporation, Gyeonggi-do, Korea, Republic of

Joon Young Park

Samyang Biopharmaceuticals Corporation, Gyeonggi-do, Korea, Republic of

So-Young Kim

Samyang Biopharmaceuticals Corporation, Gyeonggi-do, Korea, Republic of

Gyu-Young Moon

Samyang Biopharmaceuticals Corporation, Gyeonggi-do, Korea, Republic of

Ji-Hye Choi

Samyang Biopharmaceuticals Corporation, Gyeonggi-do, Korea, Republic of

Suk-Hwan Kim

Samyang Biopharmaceuticals Corporation, Gyeonggi-do, Korea, Republic of

Minhyuk Yun

Samyang Biopharmaceuticals Corporation, Gyeonggi-do, Korea, Republic of

Hye Yeong Nam

Samyang Biopharmaceuticals Corporation, Gyeonggi-do, Korea, Republic of

Helen Cho

Samyang Biopharmaceuticals Corporation, Gyeonggi-do, Korea, Republic of